RecallDepth
Class II Terminated

metFORMIN HCL ER 500 mg, a) 30 tablets (NDC 72789-009-30); b) 60 tablets (NDC 72789-009-60); c) 90 tablets (NDC 72789-009-90); d) 180 tablets (NDC 72789-009-93); e) 100 tablets (NDC 49483-0623-01) bottles, Rx only PD-Rx Pharmaceuticals Incorporated, Oklahoma City, OK 73127

Company
Pd-Rx Pharmaceuticals, Inc.
Recall Initiated
June 5, 2020
Posted
July 1, 2020
Recall Number
D-1333-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1969 bottles
Firm Location
Oklahoma City, OK, United States

Reason for Recall

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Distribution

United States.

Lot / Code Info

Lots: a) A20B02, I19D03, J19A98, K19E32, L19C86 Exp. 12/31/2020; b) I19D55, I19F50, K19A18, K19D87, L19B34, L19D23, L19E74 Exp. 12/31/2020; c) I19E91, I19F33, J19B88, J19E70, K19D26, L19A65 Exp. 12/31/2020; d) I19C21 Exp. 08/21/2020, I19C57, J19C21, J19C67, K19B53, L19C77, L19E44 Exp. 12/31/2020; e) XP9004 Exp. 12/31/2020

More recalls by Pd-Rx Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls